|
advertisement
|
|
|
| Journal Articles Details
|
|
More November, 2004 pharmacogenomics journal articles.- In genetic control of disease, does 'race' matter?
by Goldstein DB, Hirschhorn JN.
Journal: Nat Genet. 36(12):1243-1244
- Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections.
by Wunderink RG, Waterer GW.
Journal: Infect Dis Clin North Am. 18(4):743-59, vii
- Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors.
by García-Colunga J, Vázquez-Gómez E, Miledi R.
Journal: Pharmacogenomics J. 4(6):388-93
- Genetic predictors of the clinical response to opioid analgesics : clinical utility and future perspectives.
by Lötsch J, Skarke C, Liefhold J, Geisslinger G.
Journal: Clin Pharmacokinet. 43(14):983-1013
- [P-glycoprotein--a pump of significance for drug response]
by Molden E.
Journal: Tidsskr Nor Laegeforen. 124(22):2921-3
- The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development.
by Walker DK.
Journal: Br J Clin Pharmacol. 58(6):601-608
- Interethnic variability of ERCC2 polymorphisms.
by King CR, Yu J, Freimuth RR, McLeod HL, Marsh S.
Journal: Pharmacogenomics J. 11 2004;:
- Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management.
by Kajinami K, Takekoshi N, Brousseau ME, Schaefer EJ.
Journal: Atherosclerosis. 177(2):219-34
- Childhood and adolescent lymphoid and myeloid leukemia.
by Pui CH, Schrappe M, Ribeiro RC, Niemeyer CM.
Journal: Hematology (Am Soc Hematol Educ Program). :118-45
- Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs.
by Zineh I, Gerhard T, Aquilante CL, Beitelshees AL, Beasley BN, Hartzema AG.
Journal: Pharmacogenomics J. 4(6):354-8
- Internet based clinical trial protocols -- as applied to a study of warfarin pharmacogenetics.
by Lindh JD, Kublickas M, Westgren M, Rane A.
Journal: Br J Clin Pharmacol. 58(5):482-7
- CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians.
by Vasconcelos GM, Struchiner CJ, Suarez-Kurtz G.
Journal: Pharmacogenomics J. 11 2004;:
- Pharmacogenetics of acute lymphoblastic leukemia.
by Mehta PA, Davies SM.
Journal: Curr Opin Hematol. 11(6):434-438
- Gene expression microarray technologies in the development of new therapeutic agents.
by Clarke PA, te Poele R, Workman P.
Journal: Eur J Cancer. 40(17):2560-91
- Aggresome formation and pharmacogenetics: sulfotransferase 1A3 as a model system.
by Wang L, Yee VC, Weinshilboum RM.
Journal: Biochem Biophys Res Commun. 325(2):426-33
- Identification of a pharmacogenetic effect by linkage disequilibrium mapping.
by Xu CF, Lewis KF, Yeo AJ, McCarthy LC, Maguire MF, Anwar Z, Danoff TM, Roses AD, Purvis IJ.
Journal: Pharmacogenomics J. 4(6):374-8
- The catechol-O-methyltransferase Val(108/158)Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.
by Szegedi A, Rujescu D, Tadic A, Müller MJ, Kohnen R, Stassen HH, Dahmen N.
Journal: Pharmacogenomics J. 11 2004;:
- Pharmacogenomics in cancer therapy: is host genome variability important?
by Petros WP, Evans WE.
Journal: Trends Pharmacol Sci. 25(9):457-64
- Pharmacogenetics research network and knowledge base fourth scientific meeting.
by Davis AF, Long RM.
Journal: Pharmacogenomics J. 4(6):359-61
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|